The National Heart, Lung, and Blood Institute Progenitor Cell Translational Consortium Blood Progenitor Meeting was hosted virtually on November 5, 2020, with 93 attendees across 20 research groups. The purpose of this meeting was to exchange recent findings, discuss current efforts, and identify prospective opportunities in the field of hematopoietic stem and progenitor cell research and therapeutic discovery.

中文翻译：

---

从开发到治疗，血液祖细胞的协作努力

国家心肺血液研究所祖细胞转化联盟血液祖细胞会议于 2020 年 11 月 5 日以虚拟方式召开，来自 20 个研究小组的 93 名与会者参加了会议。这次会议的目的是交流最新的发现，讨论当前的努力，并确定造血干细胞和祖细胞研究和治疗发现领域的潜在机会。